Literature DB >> 11772957

Positive suggestions about the anti-HBc positive donor.

D Mutimer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11772957      PMCID： PMC1773064          DOI： 10.1136/gut.50.1.7

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  De novo hepatitis B infection acquired during liver transplantation.

Authors:  P J Gow; D J Mutimer
Journal:  QJM       Date:  2001-05

2.  Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.

Authors:  A S Yu; J M Vierling; S D Colquhoun; W S Arnaout; C K Chan; E Khanafshar; S A Geller; W S Nichols; T L Fong
Journal:  Liver Transpl       Date:  2001-06       Impact factor: 5.799

3.  De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.

Authors:  M Prieto; M D Gómez; M Berenguer; J Córdoba; J M Rayón; M Pastor; A García-Herola; D Nicolás; D Carrasco; J F Orbis; J Mir; J Berenguer
Journal:  Liver Transpl       Date:  2001-01       Impact factor: 5.799

4.  Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.

Authors:  S F Dodson; C A Bonham; D A Geller; T V Cacciarelli; J Rakela; J J Fung
Journal:  Transplantation       Date:  1999-10-15       Impact factor: 4.939

5.  Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

Authors:  R C Dickson; J E Everhart; J R Lake; Y Wei; E C Seaberg; R H Wiesner; R K Zetterman; T L Pruett; M B Ishitani; J H Hoofnagle
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

6.  Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants.

Authors:  S Uemoto; K Sugiyama; H Marusawa; Y Inomata; K Asonuma; H Egawa; T Kiuchi; Y Miyake; K Tanaka; T Chiba
Journal:  Transplantation       Date:  1998-02-27       Impact factor: 4.939

7.  Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.

Authors:  A M Roque-Afonso; C Feray; D Samuel; D Simoneau; B Roche; J-F Emile; M Gigou; D Shouval; E Dussaix
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

8.  Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation.

Authors:  R Segovia; A Sánchez-Fueyo; A Rimola; L Grande; M Bruguera; J Costa; C Soguero; J Uriz
Journal:  Liver Transpl       Date:  2001-02       Impact factor: 5.799

9.  The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.

Authors:  M E Wachs; W J Amend; N L Ascher; P N Bretan; J Emond; J R Lake; J S Melzer; J P Roberts; S J Tomlanovich; F Vincenti
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.